Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Intuitive Surgical, Inc. (ISRG) vs Progressive Corp (PGR) Price & Performance

Intuitive Surgical, Inc.Trade
Progressive CorpTrade

Price performance (Past 24H)

Key statistics

Intuitive Surgical, Inc. vs Progressive Corp — how do they compare? Intuitive Surgical, Inc. trades at $357.45 (market cap $125.08B), while Progressive Corp trades at $206.97 (market cap $123.39B). The key difference: Intuitive Surgical, Inc. and Progressive Corp are close in size by market cap, and Progressive Corp pays a 6.55% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals.

ISRGPGR
Market Cap
$125.08B$123.39B
Sector
HealthFinancials
52-Week High
$592.85$252.68
52-Week Low
$345.42$190.40
Enterprise Value
$116.45B$131.61B
Dividend Yield
6.55%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Intuitive Surgical, Inc.

Intuitive Surgical (ISRG) trades at $354.00, up 2.48% today, but remains near its 52-week low of $344.55. The stock faces technical bearish pressure despite strong Q2 2026 earnings beats, with revenue reaching $10.06B in 2025 and net income margin at 28.45%. Recent news highlights investor concerns over moderated U.S. procedure growth and a cautious 2026 outlook, driving the stock's recent decline.

The outlook balances robust fundamentals against near-term headwinds. Wall Street maintains a bullish consensus price target of $504.56, but risks include slowing procedure growth and insurance-related challenges. Long-term growth drivers like global da Vinci adoption and AI integration offer upside, though volatility may persist amid sentiment shifts.

Progressive Corp

PGR trades at $211.22, up 1.57% over 24 hours, with a bearish technical signal but neutral oscillators. The stock shows strong fundamentals with revenue growth from $49.6B in 2022 to $87.6B in 2025 and net income margin expanding to 12.9%. Recent Q2 2026 earnings matched expectations at $4.64 EPS. Analyst consensus price target is $234.56 with 37% buy ratings, though technical resistance looms near $212.

Outlook remains cautiously optimistic given Progressive's earnings consistency and valuation at 10.43 P/E, but risks include competitive pressures and potential earnings volatility. The stock offers value with dividend yield support, though investors should monitor premium growth sustainability amid economic uncertainty.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Intuitive Surgical, Inc.

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.

Read more on ISRG

About Progressive Corp

Progressive underwrites private and commercial auto insurance and specialty lines

Read more on PGR